For this latest analysis, researchers explored real-world data from more than 90,000 HFpEF patients with obesity and type 2 diabetes who received treatment from 2018 to 2024
This combination has gained significant research attention for aging-related glutathione deficiency
Biological Psychiatry, 53(3), 193-203
The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD
Formacin continua Contenidos seleccionados para mantenerle al da
Las tumoraciones se desarrollan progresivamente, pudiendo ocasionar severa deformacin, y en 15% de los pacientes sufren malignizacin